Wuxi Biologics (Cayman) Overview

Wuxi Biologics (Cayman) Total Revenue

Revenue analysis for WXXWY.

Quarterly Revenue

$11.62B

↑ 15.02% YoY

As of Dec 2025

Annual Revenue (TTM)

$40.25B

↑ 24.59% YoY

Trailing 12 months ending Dec 2025

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin